Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Soleno Therapeutics Inc
SLNO | US
52.25
USD12.76
32.31%
SLNO | US
Loading StockChartView...
About Soleno Therapeutics Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
06/04/2026
Close
52.25
Open
52.30
High
52.38
Low
52.15
Soleno Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia Inc. and changed its name to Soleno Therapeutics Inc. in May 2017. Soleno Therapeutics Inc. was incorporated in 1999 and is based in Redwood City California.
View LessSLNO | US
Risk
138.0
Sharpe
-0.47
Luna's Score
49/100
Recommendation
Hold
Luna says (SLNO | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
175.2%1 month
138.0%3 months
89.8%6 months
83.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
7.41
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
0.02
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-66.53M
MarketCap
2.03B
MarketCap(USD)
2.03B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-44.62
Short ratio
10.39
Short perc.
20.70
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
22.91
Range1M
22.91
Range3M
22.91
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
12.51
Price X volume
3.03B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.02 | 12.67 | Cheaper |
| Ent. to Revenue | - | 44.00 | - |
| PE Ratio | - | 40.09 | - |
| Price to Book | 7.41 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 89.77 | 59.59 | Riskier |
| Debt to Equity | 0.00 | -14.36 | Expensive |
| Debt to Assets | 0.00 | 0.34 | Cheaper |
| Market Cap | 2.03B | 13.71B | Emerging |
